Atlas Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Clinical trial NCT06193031 · COMPLETED

Trial details

NCT number
NCT06193031
Sponsor
Insmed Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2015-11-17
Primary completion
2015-12-18
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.